Related Experiment Video
Updated: Jan 23, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral
Samira Dahesh1, Brian Wong2, Victor Nizet1,3
1University of California San Diego School of Medicine, La Jolla, California, USA.
Abstract:
Weekly oritavancin plus ampicillin continuous infusion combination therapy was used to successfully treat a deep spine vancomycin-resistant Enterococcus faecium infection associated with hardware. Checkerboard and time-kill assays confirmed synergy between these two antibiotics. Further synergies of oritavancin and ampicillin with rifampin or the endogenous human antimicrobial peptide cathelicidin LL-37 were demonstrated.
Insights
Weekly oritavancin and ampicillin combination therapy successfully treated a deep spine infection caused by vancomycin-resistant Enterococcus faecium. Synergy was confirmed in vitro, with further potential synergies identified.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Deep spine infections pose significant treatment challenges, particularly those caused by multidrug-resistant organisms.
- Vancomycin-resistant Enterococcus faecium (VRE) is a problematic pathogen in healthcare-associated infections.
- Novel therapeutic strategies are needed to combat resistant bacterial infections.
Observation:
- A patient with a deep spine infection due to vancomycin-resistant Enterococcus faecium (VRE) associated with hardware was treated.
- The treatment regimen involved weekly oritavancin plus ampicillin administered via continuous infusion.
- In vitro assays were performed to evaluate the antimicrobial activity of the combination therapy.
Findings:
- The combination therapy of weekly oritavancin and ampicillin successfully treated the deep spine VRE infection.
- Checkerboard and time-kill assays demonstrated synergistic activity between oritavancin and ampicillin.
- Additional synergistic effects were observed when oritavancin and ampicillin were combined with rifampin or cathelicidin LL-37.
Implications:
- This study highlights a potential effective treatment strategy for challenging VRE spine infections.
- The demonstrated in vitro synergy supports further investigation into oritavancin-based combination therapies.
- Identifying synergistic partners like rifampin or LL-37 could lead to enhanced treatment options for resistant infections.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...